Edoxaban in NVAF Flashcards
Edoxaban PK
BA = 62%, Anticoagulation onset = 1-2 hr, half-life = 9-10 hr
Edoxaban NVAF Dose
60 mg once daily
Edoxaban NVAF Dose Adjustment
30 mg once daily - CrCl 15–50 mL/min/1.73 m2
Edoxaban Avoid Use NVAF
- CrCl > 95 mL/min/1.73 m2
- CrCl < 15 mL/min/1.73 m2, Dialysis
- Rifampin
- Chemotherapy agents
Converting from Edoxaban Oral to Warfarin
For patients taking 60 mg of edoxaban, reduce the dose to 30 mg and begin warfarin concomitantly. For patients receiving 30 mg of edoxaban, reduce the dose to 15 mg and begin warfarin concomitantly. The INR must be measured at least weekly and just before the daily dose of edoxaban to minimize the influence of edoxaban on INR measurements. Once a stable INR ≥ 2.0 is achieved, edoxaban should be discontinued and warfarin continued
Converting from Parenteral Edoxaban to Warfarin
Discontinue edoxaban, and administer a parenteral anticoagulant and warfarin at the time of the next scheduled edoxaban dose. Once a stable INR ≥ 2.0 is achieved, the parenteral anticoagulant should be discontinued and warfarin continued
Converting from Edoxaban to Anticoagulants (with rapid onset) Other than Warfarin
Discontinue edoxaban, and begin the new anticoagulant (oral or parenteral; other than warfarin) at the usual time of the next dose of edoxaban
Converting from Warfarin to Edoxaban
Discontinue warfarin and start edoxaban when the INR is ≤ 2.5
Converting from Anticoagulants (with rapid onset) Other than Warfarin to Edoxaban
Discontinue the other oral anticoagulant (other than warfarin) or LMWH, and begin taking edoxaban at the usual time of the next dose of the other anticoagulant. For UFH administered by continuous infusion, stop the infusion and start edoxaban 4 hr later